
zzso and zzso markers zzso in invasive breast zzso are limited and include zzso zzso zzso and zzso zzso In the case of zzso zzso or amplification serves as eligibility for zzso based therapy, including zzso zzso zzso While clinical trials have shown zzso improves overall survival and time to zzso an zzso response to zzso based therapy is highly zzso This suggests that, in a zzso zzso positive population, additional markers could help in predicting patient outcome to zzso Here we zzso a recently validated zzso zzso zzso zzso and generated a standard clinical zzso scoring zzso zzso zzso utilizing two breast zzso zzso 1) patients receiving zzso zzso zzso and 2) patients receiving zzso for zzso disease zzso Our zzso zzso showed significant correlation with high sensitivity zzso performed on matched patients zzso In addition, patients with zzso zzso status showed a significant delay in development of zzso after zzso zzso therapy zzso zzso and showed a significant improvement in progression free survival after zzso zzso therapy zzso These findings suggest zzso zzso used in conjunction with a standard zzso testing algorithm, could aid in predicting clinical outcome and help identify patients likely to show improved response to zzso zzso 

